EFSA publishes all its scientific outputs, including its scientific opinions, in the EFSA Journal. It also issues a range of supporting publications. See also Definitions of EFSA Scientific Outputs and Supporting Publications.
EFSA carries out the risk assessment of genetically modified organisms (GMOs) submitted under Regulation (EC) 1829/2003 and Regulation (EU) 503/2013. Dietary exposure is an essential element of the risk assessment on genetically modified (GM) foods. Dieta ...
Following a request from the European Commission, EFSA assessed the 2017 post‐market environmental monitoring (PMEM) report on the cultivation of Cry1Ab‐expressing maize event MON 810. Like previous years, partial compliance with refuge requirements is re ...
To guide and assist applicants for the preparation and presentation of genetically modified (GM) plant market authorization applications, the GMO Panel of EFSA has developed guidance for the risk assessment of GM plants and derived food and feed, which de ...
To guide and assist applicants for the preparation and presentation of genetically modified (GM) plant market authorization applications, the GMO Panel of EFSA has developed guidance for the risk assessment of GM plants and derived food and feed, which de ...
In specific contract No 9 issued under the framework agreement OC/EFSA/AMU/2015/02, EFSA requested Open Analytics to implement a web application for tracking national risk assessment activities. The web application has three modules: one for visualization ...
This report describes the tasks performed in the period 1/3/2017 to 27/11/2018 under the EFSA contract OC/EFSA/GMO/2014/01, Lot 2 on toxicological studies and animal feeding studies included in applications for market authorisation of genetically modified ...
Based on the risk assessment of genetically modified plants, according to Implementing Regulation (EU) No 503/201321 “In cases when known functional aspects of the newly expressed protein or structural similarity to known strong adjuvants may indicate pos ...
In specific contract No 7 issued under the framework agreement OC/EFSA/AMU/2015/02, EFSA requested Open Analytics to extend the Web application for Benchmark Dose Modelling built under specific contracts No 3 and No 4. The Web application is further devel ...
A web application for PROAST, a software package for BMD modelling, was developed to make the use of the BMD approach significantly easier for toxicologists and risk assessors. In addition, model averaging was included in the software, for the most freque ...
In recent years, the development of innovative tools in genomics, transcriptomics, proteomics and metabolomics (designated collectively as 'omics technologies) has opened up new possibilities for applications in scientific research and led to the ava ...
EFSA Journal on Wiley